GOJO Industries announces the results of a series of independent lab studies testing the ability of instant hand sanitizers to meet the Food and Drug Administration (FDA)'s Healthcare Personnel Handwash germ kill requirements at various dosage levels.
The studies, which included more than 20 different hand sanitizers, concluded that the patent-pending PURELL Advanced Instant Hand Sanitizer formulation is the only one to meet FDA germ kill requirements with a single 1.2 mL dispense. All other hand sanitizers in the tests failed to meet performance requirements at a 2.0 mL dose, even when they contained a higher percentage of alcohol.
The studies, conducted at BioSciences Laboratories in Bozeman, Mont., used the Healthcare Personnel Handwash test methodology as described in the FDA Tentative Final Monograph for Healthcare Antiseptic Drug Products (21 CFR Parts 333 and 369). While the monograph sets the standard for product performance in healthcare settings, the findings are important for all types of businesses that provide hand sanitizers to help reduce the spread of germs.
"Whether in a workplace, school, healthcare facility or a public setting like a restaurant, casino or health club, people have an expectation of high performance when hand sanitizer is provided," says Tim Dye, GOJO North American business general manager and vice president. "Our newest dispensers, the PURELL ADX and LTX systems, are designed to deliver 1.2 mL of hand sanitizer, providing users with the assurance that they are getting the right amount of product for effective germ kill every time." Â
PURELL Advanced Instant Hand Sanitizer formulations contain a patent-pending blend of ingredients that maximize the impact of alcohol on bacteria while maintaining skin moisture for optimal skin health. A blend of four different skin conditioners moisturize skin and continue to promote skin health with repeated use.  Â
Additionally, GOJO announces the introduction of the new PURELL LTX Touch Free Dispensing System. The new touch-free system is the latest hand sanitizer dispenser innovation, offering elegant, sustainable design and reliable performance. GOJO provides a Lifetime Performance Guarantee on the dispensers that even includes the batteries. The dispensers are available in solid white or in black with a brushed chrome finish. Two sizes are available: a high-capacity 1200 mL system for high traffic locations; and a compact, 700 mL system for areas where space is limited.Â
References:
1.Based on top selling hand sanitizers for general hand antisepsis according to GHX hand sanitizer sales data 12 months ending December 2011.
2.Healthcare Personnel Handwash Study #110103-101, April 5, 2011, BioScience Laboratories, Bozeman, Mont.
3.Healthcare Personnel Handwash Study #100907-101, January 6, 2011, BioScience Laboratories, Bozeman, Mont.
4.Healthcare Personnel Handwash Study #111016-101, March 19, 2012, BioScience Laboratories, Bozeman, Mont.
Source: GOJO Industries
Tackling Health Care-Associated Infections: SHEA’s Bold 10-Year Research Plan to Save Lives
December 12th 2024Discover SHEA's visionary 10-year plan to reduce HAIs by advancing infection prevention strategies, understanding transmission, and improving diagnostic practices for better patient outcomes.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.